Tissue Array Specification Sheet
| Product Name: | Multiple organ paired normal and cancer (8 types) tissue array, 48 cases/48 cores 3 Slides Price: $277 , 5 Slides Price: $452 |
|---|
| Array Panel: | Multiple organ paired normal and cancer tissue microarray, single core, 8 types of disease and normal organs (liver, colon, stomach, esophagus, intestine, pancreas, lung and epiploon) |
|---|
| Cat No. |
Cases |
Layout |
Cores |
Diameter |
Thickness |
Standard IHC |
| BC00112 |
48 |
6 x 8 |
48 |
1.5 mm |
5 µm |
Anti-Cytokeratin (CK) confirmed |
Microarray Panel Display
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Type † |
| A1 |
1 |
M |
46 |
Liver |
Hepatocellular carcinoma |
I |
Malignant |
| A2 |
2 |
M |
44 |
Colon |
Adenocarcinoma |
I |
Malignant |
| A3 |
3 |
M |
60 |
Stomach |
Adenocarcinoma |
II |
Malignant |
| A4 |
4 |
M |
59 |
Esophagus |
Squamous cell carcinoma |
I |
Malignant |
| A5 |
5 |
M |
66 |
Intestine |
Adenocarcinoma |
I |
Malignant |
| A6 |
6 |
F |
60 |
Pancreas |
Cancer adjacent tissue |
- |
Malignant |
| A7 |
7 |
M |
46 |
Lung |
Squamous cell carcinoma |
II |
Malignant |
| A8 |
8 |
M |
60 |
Epiploon |
Metastatic mucinous adenocarcinoma |
II |
Metastasis |
| B1 |
9 |
M |
42 |
Liver |
Hepatocellular carcinoma |
II |
Malignant |
| B2 |
10 |
M |
75 |
Colon |
Adenocarcinoma |
I-II |
Malignant |
| B3 |
11 |
F |
55 |
Stomach |
Adenocarcinoma |
III |
Malignant |
| B4 |
12 |
M |
75 |
Esophagus |
Squamous cell carcinoma |
II |
Malignant |
| B5 |
13 |
M |
57 |
Intestine |
Adenocarcinoma |
II |
Malignant |
| B6 |
14 |
F |
68 |
Pancreas |
Duct adenocarcinoma |
II |
Malignant |
| B7 |
15 |
M |
57 |
Lung |
Squamous cell carcinoma |
III |
Malignant |
| B8 |
16 |
F |
57 |
Epiploon |
Metastatic adenocarcinoma |
III |
Metastasis |
| C1 |
17 |
M |
77 |
Liver |
Hepatocellular carcinoma |
II |
Malignant |
| C2 |
18 |
M |
24 |
Colon |
Mucinous adenocarcinoma |
III |
Malignant |
| C3 |
19 |
M |
74 |
Stomach |
Adenocarcinoma |
III |
Malignant |
| C4 |
20 |
M |
58 |
Esophagus |
Squamous cell carcinoma |
II |
Malignant |
| C5 |
21 |
F |
78 |
Intestine |
Adenocarcinoma |
III |
Malignant |
| C6 |
22 |
F |
15 |
Pancreas |
Islet cell carcinoma |
- |
Malignant |
| C7 |
23 |
F |
36 |
Lung |
Atypical carcinoid |
- |
Malignant |
| C8 |
24 |
M |
52 |
Epiploon |
Metastatic adenocarcinoma |
III |
Metastasis |
| D1 |
25 |
M |
56 |
Liver |
Cancer adjacent normal hepatic tissue |
- |
Normal |
| D2 |
26 |
M |
49 |
Colon |
Cancer adjacent normal colonic tissue |
- |
Normal |
| D3 |
27 |
M |
22 |
Stomach |
Cancer adjacent normal gastric tissue |
- |
Normal |
| D4 |
28 |
F |
42 |
Esophagus |
Cancer adjacent normal esophageal tissue |
- |
Normal |
| D5 |
29 |
M |
40 |
Intestine |
Cancer adjacent normal small intestinal tissue |
- |
Normal |
| D6 |
30 |
F |
14 |
Pancreas |
Cancer adjacent normal pancreatic tissue |
- |
Normal |
| D7 |
31 |
M |
40 |
Lung |
Cancer adjacent normal lung tissue |
- |
Normal |
| D8 |
32 |
F |
55 |
Epiploon |
Cancer adjacent normal greater omentum tissue |
- |
Normal |
| E1 |
33 |
F |
2 |
Liver |
Cancer adjacent normal hepatic tissue |
- |
Normal |
| E2 |
34 |
M |
35 |
Colon |
Cancer adjacent normal colonic tissue |
- |
Normal |
| E3 |
35 |
F |
50 |
Stomach |
Cancer adjacent normal gastric tissue |
- |
Normal |
| E4 |
36 |
M |
24 |
Esophagus |
Cancer adjacent normal esophageal tissue |
- |
Normal |
| E5 |
37 |
F |
35 |
Intestine |
Cancer adjacent normal small intestinal tissue |
- |
Normal |
| E6 |
38 |
F |
2 |
Pancreas |
Cancer adjacent normal pancreatic tissue |
- |
Normal |
| E7 |
39 |
M |
50 |
Lung |
Cancer adjacent normal lung tissue |
- |
Normal |
| E8 |
40 |
F |
50 |
Epiploon |
Cancer adjacent normal greater omentum tissue |
- |
Normal |
| F1 |
41 |
F |
50 |
Liver |
Cancer adjacent normal hepatic tissue |
- |
Normal |
| F2 |
42 |
M |
58 |
Colon |
Cancer adjacent colonic mucosa tissue (chronic inflammation) |
- |
Normal |
| F3 |
43 |
M |
49 |
Stomach |
Cancer adjacent normal gastric tissue |
- |
Normal |
| F4 |
44 |
F |
21 |
Esophagus |
Cancer adjacent normal esophageal tissue |
- |
Normal |
| F5 |
45 |
M |
49 |
Intestine |
Cancer adjacent normal small intestinal tissue |
- |
Normal |
| F6 |
46 |
F |
35 |
Pancreas |
Cancer adjacent normal pancreatic tissue |
- |
Normal |
| F7 |
47 |
M |
49 |
Lung |
Cancer adjacent normal lung tissue |
- |
Normal |
| F8 |
48 |
M |
58 |
Epiploon |
Cancer adjacent normal greater omentum tissue |
- |
Normal |
, . † For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
Staining Scoring: '-' - no staining; '+-' - borderline staining; '+' - weak staining; '++' - moderate staining; '+++' - strong staining; '%' - percentage of positive cells.
TNM grading:
T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum
N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes
M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis
